Summary
Clinical Laserthermia Systems AB (CLS) is a medical equipment company that develops and markets instruments for the treatment of cancer. The company offers Tranberg, a thermal therapy system developed for image guided high precision treatment of soft tissues and ablation procedures. Tranberg is approved in Europe for immune stimulating interstitial thermotherapy (imILT) treatments. CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its product to hospitals and specialist clinics involved surgical oncology and oncologic interventional radiology and has operations for clinical studies in Italy, France, Germany, UK, Sweden and Portugal for different indications. CLS is headquartered Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents
List of Tables
List of Figures
Clinical Laserthermia Systems AB Company Overview
Clinical Laserthermia Systems AB Company Snapshot
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
Clinical Laserthermia Systems AB – Pipeline Analysis Overview
Business Description
Clinical Laserthermia Systems AB - Key Facts
Clinical Laserthermia Systems AB - Major Products and Services
Clinical Laserthermia Systems AB Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Clinical Laserthermia Systems AB Pipeline Products Overview
imILT Software
imILT Software Product Overview
TRANBERG Cancer Immunotherapy System - Breast Cancer
TRANBERG Cancer Immunotherapy System - Breast Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Clinical Trial
TRANBERG Cancer Immunotherapy System - Skin Cancer
TRANBERG Cancer Immunotherapy System - Skin Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Solid Cancers
TRANBERG Cancer Immunotherapy System - Solid Cancers Product Overview
TRANBERG Cancer Immunotherapy System - Solid Cancers Clinical Trial
Tranberg CLS Thermal Therapy System - Prostate Cancer
Tranberg CLS Thermal Therapy System - Prostate Cancer Product Overview
Tranberg CLS Thermal Therapy System - Prostate Cancer Clinical Trial
Clinical Laserthermia Systems AB - Key Competitors
Clinical Laserthermia Systems AB - Key Employees
Clinical Laserthermia Systems AB - Key Employee Biographies
Clinical Laserthermia Systems AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Clinical Laserthermia Systems AB, Recent Developments
Oct 17, 2019: Clinical Laserthermia Systems Americas names Michael Magnani as managing director
Oct 08, 2019: Desert Medical Imaging doctors presented interim clinical study results of MR-guided FLA treatment of MR-visible prostate cancer at AdMeTech 4th Global Summit
Oct 07, 2019: Toronto General Hospital physicians presented interim clinical study results for MR-guided FLA treatment of low-intermediate risk localized prostate cancer at AdMeTech 4th Global Summit
Oct 04, 2019: CLS poster presented at 9th Annual Brain Mets Congress
Oct 02, 2019: CLS Presents Poster on “Laser Thermal Therapy for Brain Metastases” at 9th Annual Brain Mets Congress in Marseille, France
Sep 25, 2019: CLS presents poster at 9th Annual Brain Mets Congress in Marseille, France, 4-5 October
May 07, 2019: CLS presents image-guided laser immunotherapy system at 16th Annual Anglonordic Life Science Investor Conference
Mar 25, 2019: CLS presents MRI-guided, laser ablation solutions for prostate cancer at CME-Accredited Conferences in London, Paris & Amsterdam
Mar 25, 2019: CLS presents studies for image-guided laser, heat-induced cancer immunotherapy for tumors at ECIO 2019
Mar 05, 2019: New article on FLA treatment of prostate cancer published in JVIR. CLS partner, Dr Eric Walser, UTMB, is one of the co-authors.
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
Clinical Laserthermia Systems AB Pipeline Products by Indication
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Clinical Laserthermia Systems AB, Key Facts
Clinical Laserthermia Systems AB, Major Products and Services
Clinical Laserthermia Systems AB Number of Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Pipeline Products Summary by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Clinical Laserthermia Systems AB Ongoing Clinical Trials Summary
imILT Software - Product Status
imILT Software - Product Description
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - An Open-label, Comparative Trial to Evaluate the Effect of imILT in Patients with Advanced Disease or Stage IV Pancreatic Carcinoma
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Status
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Description
TRANBERG Cancer Immunotherapy System - Solid Cancers - Intratumoral Injection of IP-001 Following Thermal Ablation in Patients with Advanced Solid Tumors. A Multicenter Phase Ib/IIa Trial with Expansion Cohorts in Melanoma and Soft Tissue Sarcoma Patients
Tranberg CLS Thermal Therapy System - Prostate Cancer - Product Status
Tranberg CLS Thermal Therapy System - Prostate Cancer - Product Description
Tranberg CLS Thermal Therapy System - Prostate Cancer - Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
Tranberg CLS Thermal Therapy System - Prostate Cancer - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study
Tranberg CLS Thermal Therapy System - Prostate Cancer - MRI Guided Focal Laser Ablation of Prostate Cancer
Clinical Laserthermia Systems AB, Key Employees
Clinical Laserthermia Systems AB, Key Employee Biographies
Clinical Laserthermia Systems AB, Subsidiaries
Glossary
List of Figures
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
Clinical Laserthermia Systems AB Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
